[Chlamydia pneumoniae and cardiovascular diseases]
- PMID: 15518326
[Chlamydia pneumoniae and cardiovascular diseases]
Abstract
The theories formulated to explain atherogenesis evolved from vessel wall lipid to endothelial dysfunction with vascular wall remodelling. Chlamydia pneumoniae has been demonstrated to play an important role in the development of inflammatory and immunological process and can initiate atherogenesis. This pathogen is found in atherosclerotic plaques, which can induce complex activation of local inflammatory and immunological events and lead to the development of unstable plaque, vascular remodelling and vessel lumen constriction.
Similar articles
-
The presence of Chlamydia pneumoniae in atherosclerotic plaques--a report of three cases of ischaemic heart disease.Pol J Pathol. 1999;50(2):93-7. Pol J Pathol. 1999. PMID: 10481533
-
Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue.J Infect Dis. 2000 Jun;181 Suppl 3:S441-3. doi: 10.1086/315617. J Infect Dis. 2000. PMID: 10839733
-
Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology.Int J Cardiol. 2003 Jun;89(2-3):273-9. doi: 10.1016/s0167-5273(02)00507-7. Int J Cardiol. 2003. PMID: 12767552
-
[Infection and coronary atherosclerosis: the role Chlamydia pneumonia].Rev Esp Cardiol. 1998 Nov;51(11):857-63. Rev Esp Cardiol. 1998. PMID: 9859707 Review. Spanish.
-
Chlamydia pneumoniae and atherosclerosis: the role of mast cells.J Biol Regul Homeost Agents. 2009 Apr-Jun;23(2):65-9. J Biol Regul Homeost Agents. 2009. PMID: 19589286 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical